U.S. Markets closed

East Bay company's drug may shrink dialysis patient 'pill burden.' But will it help them live longer?

Ron Leuty
East Bay company's drug may shrink dialysis patient 'pill burden.' But will it help them live longer?

The Fremont company expects results from two late-stage clinical trials in kidney failure patients later this year. The same drug is expected to face a regulatory decision in September for another condition.